Table 1.

Description of sample sets.

Study set	Age (yr)	Gender (F:M)	Indication^a	Cohort name	Sample Type	References
Set 1	50–92	78:78	Population	TwinGene	Serum	Lichtenstein et al (2002) and Magnusson et al (2013)
Set 2	9–63	102:102	Population	LifeGene	Plasma	Almqvist et al (2011)
Set 3	48–93	1,613:1,386	Population	TwinGene	Serum	Lichtenstein et al (2002) and Magnusson et al (2013)
Set 4	51–86	50:0	Breast cancer
Set 5	56–75	0:50	Prostate cancer
Set 6	55–78	16:27	Cardiovascular disease	IMPROVE	Plasma	Baldassarre et al (2010)
Set 7	41–60	12:31	Myocardial infarction	SCARF	Plasma	Samnegård et al (2005)
Set 8	48–73	20:23	Acute coronary heart syndrome	CHAPS	Plasma	Odeberg et al (2014)
Set 9	40–73	600:0	Mammography	KARMA	Plasma	Gabrielson et al (2017)

↵a Subjects included in the presented study did not include individuals diagnosed with the disease of the indication area, but the subjects assigned as controls for the different disease cohorts.